Call Options

2 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2021

Feb 11, 2022

SELL
$4.64 - $7.46 $399,040 - $641,560
-86,000 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$6.05 - $12.15 $520,300 - $1.04 Million
86,000 New
86,000 $609,000

Others Institutions Holding CELU

About Celularity Inc


  • Ticker CELU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 142,424,000
  • Market Cap $319M
  • Description
  • Celularity Inc., a clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases. It operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. The company's lead therapeutic programs include CYCART-19, a placental-de...
More about CELU
Track This Portfolio

Track Peak6 Investments LLC Portfolio

Follow Peak6 Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peak6 Investments LLC with notifications on news.